BD Announces Launch of New Disposable Auto-injectors

14 Nov 2011
The BD Physioject™ is a reliable and cost-effective system, with a number of key benefits which allow for the optimised delivery of subcutaneous injections. The system is easy to use and intuitive, with one-button activation and a 360° view of the drug and injection process.

Claude Dartiguelongue, President, BD Medical – Pharmaceutical Systems, says: “BD is committed to providing high-quality, innovative, highly customisable, cost-effective devices designed specifically to meet chronic disease patients’ needs for safety, comfort and convenience. With BD Physioject™, developed through a robust, patient-centric design process, we aim to improve drug efficacy, the patient experience and treatment compliance.” Clinical trials show that BD Physioject™ provides safety, efficiency, acceptance by patients, and improved pain perception versus the same syringe used by a nurse*.

BD Physioject™ is designed for use in combination with the BD Hypak™ for Biotech syringe, a state-of-the-art primary container optimised for use with biologics. It provides, amongst other benefits, a low level of interaction with such drugs. The complete integrated system offers a high-quality, reliable solution for the self-injection market.

“We are excited to be introducing a new generation of disposable auto-injectors with the launch of BD Physioject™ and we look forward to collaborating with pharmaceutical and biotechnology companies to facilitate the development and launch of self-injection devices, with the common end goal of improving the lives of patients managing chronic diseases,” Ms. Dartiguelongue adds.

Request Info

Company website

BD Medical
profile photo

Sonia Nicholas
Clinical Diagnostics Editor